External radiotherapy plus camrelizumab as first-line therapy for unresectable intrahepatic cholangiocarcinoma demonstrated a 1-year progression-free survival rate of 44.4% and antitumor activity with low toxicity levels. The objective response rate was 61.1% and the disease control rate was 86.1%. Further investigation is warranted for this promising treatment approach.
Journal Article by Zhu M, Jin M (…) Peng Z et 7 al. in BMC Med
© 2024. The Author(s).
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in HPB & Spleen
Liver transplantation gave better 5-year survival than liver resection in combined hepatocellular-cholangiocarcinoma, including tumors within UCSF criteria.
Robotic liver resection using a close-to-open forceps technique was associated with no bile leakage and a shorter hospital stay than laparoscopic resection, even though more complex resections were performed in the robotic group.
A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.
